Triglimisave 2 HS + Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (2mg) + Metformin (1000mg) + Pioglitazone (15mg)
Overview Triglimisave 2 HS + Tablet SR
GlycemiaControl Duo is a dual-action medication formulated to manage blood glucose. Used in conjunction with diet and physical activity, it enhances glycemic control in adult patients with type 2 diabetes. This medication promotes efficient insulin use, consequently reducing blood sugar. GlycemiaControl Duo should be administered precisely as prescribed by your physician, adhering to both dosage and duration. Ingestion with food is recommended to minimize gastrointestinal discomfort. A missed dose should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Commonly reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Baseline kidney function tests will be conducted before treatment initiation. Limit alcohol consumption, as it may potentiate adverse reactions.
Primary Ingredients of Triglimisave 2 HS + Tablet SR
No text provided to rephrase.
Uses of Triglimisave 2 HS + Tablet SR
Managing Type 2 Diabetes
Major Benefits of Triglimisave 2 HS + Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Triglimisave 2 HS + Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Triglimisave 2 HS + Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimisave 2 HS + Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Triglimisave 2 HS + Tablet SR with a meal.
How Triglimisave 2 HS + Tablet SR works:
Triglimisave 2 HS + SR tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse actions to enhance blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimisave 2 HS + Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimisave 2 HS + Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimisave 2 HS + Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Triglimisave 2 HS + Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Triglimisave 2 HS + Tablet SR cautiously, potentially requiring dosage modification. Severe liver disease contraindicates the use of Triglimisave 2 HS + Tablet SR; physician consultation is advised.
What if you forget to take Triglimisave 2 HS + Tablet SR :
Should you forget a Triglimisave 2 HS + Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimisave 2 HS + Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently